SCHEDULE: BlackRock Reports Stake in Nano-X Imaging
Schedule 13G Filing
BlackRock, Inc. has disclosed a beneficial ownership stake of 0.4% in Nano-X Imaging Ltd, holding 255,435 shares.
Summary
- BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Nano-X Imaging Ltd common stock.
- The filing indicates that BlackRock, Inc. beneficially owns 255,435 shares of Nano-X Imaging Ltd common stock.
- This represents 0.4% of the total outstanding shares of the company's common stock.
- BlackRock, Inc. has sole voting power and sole dispositive power over these shares.
- The filing was made on June 30, 2026, and is an amendment to a previous filing.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. It's a routine disclosure of an existing ownership stake by a major institutional investor, providing factual information without significant positive or negative implications for the company's immediate prospects.
Positives
- BlackRock, a major institutional investor, holds a stake in Nano-X Imaging, which can be seen as a positive signal of institutional confidence.
- The filing confirms BlackRock's active management of its portfolio, with clear reporting of its holdings.
Negatives
- The ownership stake is relatively small (0.4%), suggesting BlackRock is not a controlling shareholder or a major activist investor in Nano-X Imaging.
- The filing does not provide any forward-looking statements or strategic insights from BlackRock regarding its investment.
Risks
- The filing itself does not present new risks to Nano-X Imaging, but rather reports an existing ownership stake.
- Potential future changes in BlackRock's investment strategy could lead to the sale of its stake, impacting Nano-X Imaging's stock price.
Future Outlook
No specific future outlook or guidance is provided by BlackRock in this filing regarding Nano-X Imaging.
Management Comments
- BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors like BlackRock when their ownership crosses certain thresholds. This filing indicates BlackRock's ongoing investment management activities within the medical technology sector, where Nano-X Imaging operates.
Stakeholder Impact
- Shareholders: The filing confirms a significant institutional investor's stake, which may be viewed positively by some, but the small percentage limits immediate impact.
- Management: The filing reinforces that BlackRock is not seeking to influence control, allowing management to continue with its strategic plans without immediate activist pressure from this holder.
Next Steps
- BlackRock will continue to monitor its investment in Nano-X Imaging Ltd.
- Future amendments to the Schedule 13G will be filed if BlackRock's ownership stake changes significantly.
Key Dates
| Date | Description |
|---|---|
| 04/30/2023 | Previous Power of Attorney dated for BlackRock, Inc. |
| 01/21/2025 | Effective date of new Power of Attorney for BlackRock, Inc. |
| 06/30/2026 | Date of Event Which Requires Filing of this Statement (Amendment No. 1) |
| 07/29/2026 | Signature date for BlackRock, Inc. filing |
Keywords
Nano-X Imaging, BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.